Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells

Tisheeka R. Graham, Rami Yacoub, Latonia Taliaferro-Smith, Adeboye O. Osunkoya, Valerie A. Odero-Marah, Tongrui Liu, K. Sean Kimbro, Dipali Sharma, Ruth M. O'Regan

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Zinc-finger enhancer binding protein (ZEB1) is a transcription factor involved in the progression of cancer primarily through promoting epithelial to mesenchymal transition (EMT). ZEB1 represses the expression of E-cadherin by binding to E-box sequences in the promoter, thus decreasing epithelial differentiation. We show that ZEB1 and androgen receptor (AR) cross-talk in triple negative breast cancer cell lines. Chromatin immunoprecipitation analysis demonstrates that ZEB1 binds directly to the E-box located in the AR promoter. ZEB1 suppression by stably transfecting shRNA in a triple negative breast cancer cell line resulted in a decrease of AR mRNA, protein, and AR downstream targets. ZEB1 knockdown in triple negative breast cancer cells sensitized the cells to bicalutamide by reducing migration compared to the control cells. Conversely, blockade of AR signaling with bicalutamide resulted in a suppression of ZEB1 protein expression in two triple negative breast cancer cell lines. Furthermore, using a breast cancer tissue microarray, a majority of triple negative breast cancers exhibit positive staining for both ZEB1 and AR. Taken together, these results indicate that ZEB1 and AR regulate each other to promote cell migration in triple negative breast cancer cells.

Original languageEnglish (US)
Pages (from-to)139-147
Number of pages9
JournalBreast Cancer Research and Treatment
Volume123
Issue number1
DOIs
StatePublished - Aug 2010
Externally publishedYes

Keywords

  • AR
  • Breast cancer
  • Triple negative
  • ZEB1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells'. Together they form a unique fingerprint.

Cite this